Joan Puig de Dou, CEO of Kymos Pharma, a Spanish analytical CRO, shares his insights in the changing dynamics of the industry and explains how remaining independent in the face of industry consolidation is a strategic priority to leverage both quality and specialization for the company’s clients.

The interview has been published online in Pharma Boardroom:

https://pharmaboardroom.com/interviews/joan-puig-de-dou-ceo-kymos-pharma-spain/